Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +48.45%
#3 Black Phoenix Black Phoenix +34.85%
#4 Velvet Velvet +30.94%
#5 Cross Cross +19.36%
#6 Akedo Akedo +17.98%
#7 DoubleZero DoubleZero +14.50%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.43%
#9 Fake World Assets Fake World Assets +10.49%
#10 Cap Cap +10.24%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Kedudukan dalam Saham #40870
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Harga Saham
$0.02765
Disegerakkan terakhir: 2024-12-23
Modal Pasaran
$69.04K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Histogen Inc. (HSTO)

Kategori

Healthcare
Nisbah P/B bagi Histogen Inc. (HSTO)
Nisbah P/B pada August 2026 TTM: 0.00
Menurut laporan kewangan dan harga saham terkini Histogen Inc., nisbah P/B semasa (TTM) ialah 0.00. Pada akhir 2021, nisbah P/B syarikat ialah 0.06.
Sejarah nisbah P/B untuk Histogen Inc. dari 2011 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 0.00 -77.50%
2022 0.02 -69.01%
2021 0.06 -31.54%
2020 0.09 -168.39%
2019 -0.13 -166.48%
2018 0.19 -59.34%
2017 0.47 -13.89%
2016 0.55 -98.24%
2015 31.05 -52.41%
2014 65.25 265.13%
2013 17.87 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 139,040.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 140,973.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 80,655.56%
BE